Certain psychedelics, proven to be highly safe and utilized as dissociative anesthetics since the 1970s, are included in the World Health Organization's essential medicines list. Two decades of research has shown that when psychedelics are administered in low doses and paired with psychotherapy in a clinical setting, it creates a powerful synergy for healing through the following three elements:

Immediate Antidepressant Effects: Psychedelics rapidly alleviate depressive symptoms by targeting specific brain receptors, resulting in improved mood, reduced anxiety, and enhanced receptivity for psychotherapy. Clients often report remarkable improvements in their mood, a reduction in anxiety, and an increased sense of calmness after their first session. They report feeling more open, emotionally lighter, and more connected to themselves and others.

Expedited Ability to Delve into Past Traumas: The psychedelics fast-acting antidepressant effects facilitate more efficient therapy. Clients express themselves more easily, allowing therapists to delve into trauma and emotional distress origins. Reduced emotional barriers enable deeper memory exploration, leading to effective processing and a transformation from self-criticism to clarity, calmness, and compassion.

Neurogenesis and Fresh Neural Pathways: Psychedelics prompt the brain to create new neural connections, helping individuals see past traumas in new ways. These connections promote acceptance and mental clarity. With repeated treatment sessions, these pathways become stronger, supporting positive perspectives and helping to process past trauma.